Predicting the Duration of Antibacterial Treatment with Cell Wall Synthesis Inhibitors by using Mathematical Models

Panit Suavansri

Abstract


This paper proposed a new mathematical model of within-host population dynamics of bacteria after cell wall synthesis inhibitors administration for practically predicting treatment duration and drug dosage. Our model deployed various concepts from different fields of probability, biology, physics, chemistry, pharmacology (pharmacokinetics and pharmacodynamics (PK/PD)), and medical sciences. The following assumptions and hypotheses were established: (i) binding or collision rate between drug molecule and bacteria depends on the relative velocity between drug molecule and bacteria, (ii) ability or probability of binding or capturing between drug molecule and bacteria can be evaluated by using four probability factors, based on the principal of physics and chemistry, (iii) the number of bacteria dying from antibiotics are equal to the number of drug molecules binding bacteria. Thus, bacterial death rate is equal to rate of drug molecules binding and killing bacteria (amount of drug molecules per second), and (iv) plasma drug concentration is constant and time-independent. The predicted result from our model was compared with the actual data of patient treatment and the classical Emax model derived from PK/PD models. The treatment duration with respect to drug administration of our result is closer to the actual patient treatment duration than the Emax model. It also preserves the similar recuperation rate as that of the real treatment.

Full Text:

139-148:PDF

References


Austin DJ, White NJ and Anderson RM, The Dynamics of Drug Action on the Within-host Population Growth of Infectious Agents: Melding Pharmacokinetics with Pathogen Population Dynamics, J Theor Biol. 1998; 194(3): 313-339.

Westerhof N, Stergiopulos N and Mark IM Noble, Snapshots of Hemodynamics: An Aid for Clinical Research and Graduate Education, 2010.

Amini H, Lee W and Dino Di Carlo, Inertial microfluidic physics, Lab on a Chip, 2014; 14(15): 2739-2761. DOI 10.1039/c4lc00128a

Agasanapura B, Ruth E Baltus and Chellam S, Effect of Convective Hindrance On Microfiltration of Rod Shaped Particles, AIChE Journal, Proceedings of Conference for Annual Meeting, 2011; 5-29.

Varani G, Diffusion and Molecular Shape and Size, Department of Chemistry, 2013: 4-5.

Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A, Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes, FEMS Microbiol. Rev., 2006; 30(5): 673-91.

Mazaheri A, A review of the literature, Probabilistic Modeling of Ship Grounding, Helsinki University of Technology. Faculty of Engineering and Architecture, Department of Applied Mechanics, 2009:26-34.

Berg HC and Purcell EM, Physics of chemoreception, Biophysical Journal.November, 1977; 20(2):193-219.

Taroni C, Jones S and Thornton JM, Analysis and prediction of carbohydrate binding sites, Protein Eng. 2000; 13(2): 89-98. DOI 10.1093/protein/13.2.89

Khurana I, Textbook Of Medical Physiology; Dynamics of Circulation: Pressure and Flow of Blood and Lymph, Elsevier, 2006: 327.

Dilsizian V and Pohost GM, Cardiac CT, PET and MR, Multislice Cardiac Tomography: Myocardial Function, Perfusion, and Viability, Blackwell Publishing Ltd, 2010:260.

Friedman A and Lungu EM, Can malaria parasite pathogenesis be prevented by treatment with tumor necrosis factor-alpha?, Math Biosci Eng. 2013; 10(3): 609-24. DOI 10.3934/mbe.2013.10.609.

Kim DJ, King JA, Zuccarelli L, et al., Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects. Pharmacol Biochem Behav., 2009; 93(2):112-120.

Hackett SJ, Guiver M, Marsh J, Sills JA, et al., Meningococcal bacterial DNA load at presentation correlates with disease severity, Arch Dis Child., 2002; 86(1): 44-46 DOI:10.1136/adc.86.1.44

Middelboe M, Bacterial Growth Rate and Marine Virus-Host Dynamics. Microb Ecol. 2000 Aug;40(2):114-124.

Radivoj V Krstic, Human Microscopic Anatomy: An Atlas for Students of Medicine and Biology, Springer-Verlag, 1997, Berlin Heidelberg, printed in Germany, 54-55.

Pollak AN, Emergency Care and Transportation of the Sick and Injured, Chapter 4 "The Human Body", 10th edition, 2005:108-109.

Pocock G ,Christopher D Richards and David A Richards, Human Physiology, Chapter 18 "The properties of blood", 4th edition, 2013:312-313.

Joynta GM, Lipmanb J, Gomersalla CD and et al., The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients, Journal of Antimicrobial Chemotherapy, 2001; 47: 424-425.

John R Staver and Andrew T Lumpe, A content analysis of the presentation of the mole concept in chemistry textbooks, Journal of Research in Science Teaching, 1993; 30:321-337. DOI: 10.1002/tea.3660300402

Kowalski WJ, William P Bahnfleth and Whittam TS, Filtration of Airborne Microorganisms: Modeling and Prediction, ASHRAE Transactions, 1999; 105(2): 5-6.

Bungay PM, Brenner H , The motion of a closely-fitting sphere in a fluid-filled tube. International Journal of Multiphase Flow. 1973;1(1): 25-56.

Drugs.com, Ceftriaxone - FDA prescribing information, side effects and uses, [Cited 2014 Nov 14] Available from: http://www.drugs.com/pro/ceftriaxone.html

Tom B Vree, Dammers E and Peter S Exler, Identical pattern of highly variable absorption of clavulanic acid from four different oral formulations of co-amoxiclav in healthy subjects, J Antimicrob Chemother 2003; 51:373–378. DOI 10.1093/jac/dkg082

PubChem Open Chemistry Database, U.S. National Library of Medicine, National Center for Biotechnology Information, https://pubchem.ncbi.nlm.nih.gov/compound/5280980#section=Top (Accessed 2016-02-02).

Mamdouh S Masoud, Alaa E Ali and Nessma M Nasr, Chemistry, classification, pharmacokinetics, clinical uses and analysis of beta lactam antibiotics: A review, Journal of Chemical and Pharmaceutical Research, 2014; 6(11): 28-58.

Dora E Wiskirchen, Rebecca A Keel-Jayakumar, David P. Nicolau, Chapter 3: Continuous and Intermittent Infusion Beta-Lactam Antibiotics, Casebook in Clinical Pharmacokinetics and Drug Dosing, McGraw-Hill Education / Medical; 1 edition January 7, 2015.

Robert A Freitas Jr, Section 8.5.1 “Cytometrics”, Nanomedicine, Volume I: Basic Capabilities, Landes Bioscience, Georgetown, TX, 1999. [Cited 2016 Jan 4] Available from: http://www.nanomedicine.com/NMIIA/15.4.3.1.htm

Preetam Ghosh, Chapter 4th “PROTEIN-DNA BINDING”, Stochastic models for in-silico event-based biological network simulation, Doctoral Dissertation, University of Texas at Arlington Arlington, TX, USA, copyright 2008 by ProQuest Information and Learning Company, 68-78.

Starlin R, Tammy L. Lin, Daniel M. Goodenberger, Chapter 27th “Antimicrobial Agents”, The Washington Manual Infectious Diseases Subspecialty Consult, Department of Medicine, Washington University School of Medicine, 2005, 248-257.


Refbacks

  • There are currently no refbacks.